Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Prescilla · SciRah

Researcher profile · Semantic Scholar

R. Prescilla

Share profile

R. Prescilla — researcher profile on SciRah

h-index: 14
Works: 77
Citations: 1,054

Most-cited papers

Baricitinib in adult patients with moderate‐to‐severe atopic dermatitis: A phase 2 parallel, double‐blinded, randomized placebo‐controlled multiple‐dose study
E. Guttman-Yassky, J. Silverberg, O. Nemoto, S. Forman +11 more
2018Journal of American Academy of Dermatology298 citations
Semantic Scholar
Prevalence of fetal exposure to environmental toxins as determined by meconium analysis.
E. Ostrea, V. Morales, Etienne Ngoumgna, R. Prescilla +5 more
2002Neurotoxicology165 citations
Semantic Scholar
Hemodynamic effects of dexmedetomidine sedation for CT imaging studies
K. Mason, S. Zgleszewski, R. Prescilla, Paulette J. Fontaine +1 more
2008Paediatric anaesthesia129 citations Open access
Semantic Scholar
Incidence and predictors of hypertension during high‐dose dexmedetomidine sedation for pediatric MRI
K. Mason, D. Zurakowski, S. Zgleszewski, R. Prescilla +2 more
2010Paediatric anaesthesia101 citations
Semantic Scholar
Dexmedetomidine offers an option for safe and effective sedation for nuclear medicine imaging in children.
K. Mason, F. Robinson, Paulette J. Fontaine, R. Prescilla
2013Radiology56 citations
Semantic Scholar
Pediatric CT sedation: comparison of dexmedetomidine and pentobarbital.
K. Mason, R. Prescilla, Paulette J. Fontaine, D. Zurakowski
2011AJR. American journal of roentgenology51 citations
Semantic Scholar
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
M. Cork, D. Thaçi, L. Eichenfield, P. Arkwright +7 more
2023Dermatologic Therapy38 citations Open access
Semantic Scholar
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
E. Siegfried, T. Bieber, E. Simpson, A. Paller +8 more
2021American Journal of Clinical Dermatology27 citations Open access
Semantic Scholar
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
A. Paller, A. Pinter, Lara Wine Lee, R. Aschoff +7 more
2024Advances in Therapy20 citations Open access
Semantic Scholar
A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis
E. Siegfried, Lara Wine Lee, J. M. Spergel, R. Prescilla +5 more
2024Pediatric dermatology20 citations Open access
Semantic Scholar
The synergistic effect of dexmedetomidine on propofol for paediatric deep sedation: A randomised trial.
K. Mason, R. Park, Cornelius A. Sullivan, Karina Lukovits +5 more
2020European Journal of Anaesthesiology20 citations
Semantic Scholar
Efficacy of Tranexamic Acid in Pediatric Craniosynostosis Surgery
S. Goobie, Petra M. Meier, Luis M. Pereira, F. McGowan +8 more
201519 citations
Semantic Scholar
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
A. Paller, E. Siegfried, M. Cork, A. Wollenberg +7 more
2022Pediatric Drugs17 citations Open access
Semantic Scholar
Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis
E. Simpson, M. D. de Bruin-Weller, A. Bansal, Zhen Chen +5 more
2021Dermatologic Therapy14 citations Open access
Semantic Scholar
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
E. Siegfried, E. Simpson, M. Cork, P. Arkwright +6 more
2023Dermatologic Therapy13 citations Open access
Semantic Scholar
Efficacy and safety of dupilumab treatment with concomitant topical corticosteroids in children aged 6 months to 5 years with severe atopic dermatitis
A. Paller, A. Pinter, L. Lee, R. Aschoff +8 more
2023Revue Française d'Allergologie11 citations
Semantic Scholar
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey)
A. Paller, S. Weidinger, K. Capozza, A. Pink +7 more
2023Dermatologic Therapy9 citations Open access
Semantic Scholar
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study.
A. Paller, J. Silverberg, E. Simpson, M. Cork +6 more
2024Journal of American Academy of Dermatology6 citations Open access
Semantic Scholar
SIGNIFICANT FETAL EXPOSURE TO HEAVY METALS AS DETECTED BY MECONIUM ANALYSIS.† 996
E. Ostrea, R. Prescilla, V. Morales, James Go +4 more
1997Pediatric Research6 citations
Semantic Scholar
Pharmacokinetics of Rofecoxib in Children With Sickle Cell Hemoglobinopathy
R. Prescilla, D. Frattarelli, D. Haritos, J. Aranda +1 more
2004Journal of pediatric hematology/oncology5 citations
Semantic Scholar
Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6–11 Years With And Without Comorbid Asthma
M. Boguniewicz, L. Sher, A. Paller, E. Siegfried +3 more
2021Journal of Allergy and Clinical Immunology4 citations Open access
Semantic Scholar
Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis
A. Lasek, N. Bellon, Stéphanie Mallet, H. Aubert +6 more
2025Journal of the European Academy of Dermatology and Venereology3 citations Open access
Semantic Scholar
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years
A. Paller, J. Silverberg, Mercedes E. Gonzalez, L. C. Schneider +5 more
2024Frontiers in Pediatrics3 citations Open access
Semantic Scholar
Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6–11 Years With And Without Comorbid Allergic Rhinitis
L. Beck, A. Wollenberg, A. Paller, E. Siegfried +3 more
2021Journal of Allergy and Clinical Immunology3 citations Open access
Semantic Scholar
The Pharmacology and Clinical Application of Sedatives, Analgesics, and Adjuncts
R. Prescilla
20123 citations
Semantic Scholar
342 A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis
E. Siegfried, L. Lee, J. Spergel, S. Uppal +5 more
2023British Journal of Dermatology2 citations
Semantic Scholar
27389 Rapid and sustained improvement in itch in children aged 6–11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial
A. Paller, E. Siegfried, G. Yosipovitch, J. Silverberg +5 more
20212 citations
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements
Xiaosu Ma, Charles T. Benson, R. Prescilla, Shuyu Zhang +8 more
2020Journal of Diabetes Science and Technology2 citations Open access
Semantic Scholar
Significant Fetal Exposure to Heavy Metals as Detected By Meconium Analysis: 48
E. Ostrea, R. Prescilla, V. Morales, James Go
1997Pediatric Research2 citations
Semantic Scholar
Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
A. Paller, A. Pinter, Lara Wine Lee, R. Aschoff +7 more
2024Advances in Therapy1 citations Open access
Semantic Scholar
Clinical Pharmacology of Sedatives, Reversal Agents, and Adjuncts
R. Prescilla
20211 citations
Semantic Scholar
27394 Dupilumab provides clinically meaningful improvement in atopic dermatitis (AD) signs, symptoms, and quality of life in children with severe AD: Results from the LIBERTY AD PEDS phase 3 clinical trial
A. Paller, S. Weidinger, M. Cork, D. Marcoux +7 more
20211 citations
Semantic Scholar
27431 Dupilumab treatment improves health-related quality of life in children aged ≥6 to <12 years with severe atopic dermatitis
A. Irvine, M. Deleuran, A. Praestgaard, D. Delevry +2 more
20211 citations
Semantic Scholar
Risk Perception of Musculoskeletal Injury among Critical care Nurses at Sri Ramakrishna Hospital, Coimbatore.
K. Sasikala, R. Prescilla
20161 citations Open access
Semantic Scholar
Sedation and General Anesthesia
R. Prescilla, K. Mason
20141 citations
Semantic Scholar
Safety and efficacy of up to 3 years of dupilumab treatment in infants and children with severe atopic dermatitis
A. Paller, A. Taïeb, S. Weidinger, M. Futamura +5 more
2026Revue Française d'Allergologie0 citations
Semantic Scholar
Dupilumab Treatment Up To 1 Year Reduces Allergen-Specific IgE In Young Children With Moderate-To-Severe Atopic Dermatitis
Lisa Beck, A. Paller, E. Siegfried, L. Eichenfield +5 more
2026Journal of Allergy and Clinical Immunology0 citations
Semantic Scholar
Progressive Reduction Of Allergen-Specific IgE In Children Aged 6 To 11 Years With Moderate-To-Severe Atopic Dermatitis Treated With Dupilumab
Lisa Beck, A. Paller, E. Siegfried, L. Eichenfield +5 more
2026Journal of Allergy and Clinical Immunology0 citations
Semantic Scholar
Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language summary.
E. Siegfried, M. Cork, B. Lockshin, Norito Katoh +3 more
2026Journal of dermatological treatment (Print)0 citations Open access
Semantic Scholar
Dupilumab Safety and Efficacy Up to 3 Years Across Racial Subgroups in Pediatric Patients Aged 6 Months to 11 Years With Atopic Dermatitis
E. Siegfried, M. Cork, Mercedes E. Gonzalez, R. Aschoff +5 more
2026Journal of Investigative Dermatology0 citations
Semantic Scholar
109: Dupilumab Provides Long-Term Reduction in Sleep Loss in Infants, Children, and Adolescents With Atopic Dermatitis
A. Paller, E. Simpson, E. Siegfried, M. Cork +4 more
2025Journal of Investigative Dermatology0 citations
Semantic Scholar
TOTAL IMMUNOGLOBULIN E REDUCTION WITH DUPILUMAB IN PEDIATRIC MODERATE-TO-SEVERE ATOPIC DERMATITIS: 1.5-YEAR FOLLOW-UP DATA
A. Paller, Elaine Siegfried, Lisa A. Beck, L. Eichenfield +5 more
2025Excellence in Pediatrics Abstracts0 citations Open access
Semantic Scholar
114: Dupilumab Efficacy and Safety up to 2 Years in Children Aged 6 Months to 5 Years with Atopic Dermatitis
John C. Su, A. Paller, E. Simpson, E. Siegfried +8 more
2025Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
62960 Dupilumab Safety and Efficacy Up To 3 Years In Children Aged 6 Months to 11 Years With Atopic Dermatitis
A. Paller, E. Simpson, E. Siegfried, M. Cork +7 more
2025Journal of American Academy of Dermatology0 citations
Semantic Scholar
701 - Dupilumab efficacy and safety up to 2 years in children aged 6 months to 5 years with atopic dermatitis
A. Paller, E. Simpson, E. Siegfried, M. Cork +8 more
2024British Journal of Dermatology0 citations
Semantic Scholar
DUPILUMAB TREATMENT IMPROVES ATOPIC DERMATITIS SIGNS ACROSS ANATOMICAL REGIONS IN PATIENTS AGED 12–17 YEARS
R. go, E. Siegfried, M. Cork, E. Swanson +3 more
2024Annals of Allergy, Asthma & Immunology0 citations
Semantic Scholar
52650 Dupilumab Treatment Shows Rapid and Consistent Improvement in Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 17 Years: Results From an Open-Label Extension Study
E. Siegfried, E. Simpson, M. Cork, Hidehisa Saeki +3 more
2024Journal of American Academy of Dermatology0 citations
Semantic Scholar
Long-term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
M. Crépy, E. Siegfried, M. Cork, B. Lockshin +7 more
2024Revue Française d'Allergologie0 citations
Semantic Scholar
338 Laboratory safety from a 16-week phase 3 study of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
A. Paller, A. Wollenberg, E. Siegfried, M. E. Gonzalez +5 more
2023British Journal of Dermatology0 citations
Semantic Scholar
42924 Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial
A. Paller, E. Siegfried, R. Sidbury, M. Cork +6 more
2023Journal of American Academy of Dermatology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Paller×21
Invite
A. Paller — researcher profile on SciRah
E. Siegfried×10
Invite
E. Siegfried — researcher profile on SciRah
M. Cork×9
Invite
M. Cork — researcher profile on SciRah
Zhen Chen×9
Invite
Zhen Chen — researcher profile on SciRah

×8

Invite

A. Bansal — researcher profile on SciRah

E. Siegfried×8

Invite

E. Siegfried — researcher profile on SciRah

Invite

B. Shumel — researcher profile on SciRah

Invite

K. Mason — researcher profile on SciRah

Invite

S. Cyr — researcher profile on SciRah

L. Eichenfield×5

Invite

L. Eichenfield — researcher profile on SciRah

M. Boguniewicz×5

Invite

M. Boguniewicz — researcher profile on SciRah

Invite

A. Bansal — researcher profile on SciRah